Since it is known that a broad spectrum of tumor cells lack MHC presentation and show hypermethylation of IFNγ target genes such as CIITA [31], we treated RMS cells with the demethylation reagent 5′aza 2′deoxycytidine. This evidence concerns the gene IFNG and neoplasm.